Sam Sulek's Peptide Scam
Greg Doucette's commentary on Sam Sulek's new peptide website: his claims about product quality, legal risk and marketing to young people, from a host who sells prescribed peptides himself.
Key moments
Tap a moment to play the video from there.
- 0:32Sulek launches a peptide siteDoucette introduces the story: Sam Sulek owns a peptide website, announced through an AI-made video instead of a normal talk to camera.
- 1:33Reading the backlash commentsDoucette reads comments under the ad and says about 95% are negative, aimed at the AI use and at promoting peptides to a younger audience.
- 3:36Doucette's own AlgoRX conflictHe says he owns AlgoRX and used to sell steroids, and he contrasts prescribed, compounding-pharmacy peptides with research-labelled ones.
- 4:38Doubts about product qualityHe argues the products are likely not authentic, using the cagrilintide lab report as his example because it lacks a molecular weight test.
- 6:40The price comparisonDoucette contrasts $135 for 1 mg elsewhere with $75 for ten units here and calls the gap implausible.
- 7:41A company that may mislead SulekHe suggests the people behind the company may be deceiving Sulek, and says its name and look imitate a real research supplier.
- 8:42Terms of service and the lawHe reads the site's research-only terms and says buyers who are not licensed researchers are breaking the law.
- 9:42Peptide sellers shutting downDoucette cites a seller's voluntary shutdown as a sign of legal pressure and describes the lawsuit risk if a minor buys peptides.
- 12:14Turning down peptide moneyHe describes past offers to promote or start a peptide company, which he says he refused, and explains why he works with AlgoRX.
- 13:46The gateway argumentHe closes by saying peptides could be a gateway to SARMs and steroids, then promotes his discount code.
What the video says
Greg Doucette reacts to news that bodybuilder Sam Sulek has launched a peptide website, announced through an AI-generated video. Doucette says the ad drew heavy criticism, mostly for the use of AI and for promoting peptides to a young audience. He says he is not attacking Sulek as a person, and he describes Sulek as a 23-year-old whose audience includes many teenagers.
A large part of the video is Doucette's case that the site's products are probably not what they claim to be. He says peptides are hard to make without a compounding pharmacy and tend to degrade. He points to a lab report for cagrilintide that, in his telling, shows an HPLC retention time rather than a molecular weight from mass spectrometry, which he says proves nothing. He also compares a listed price of $75 for ten units with $135 for a single 1 mg from another seller, and argues the gap makes the product implausible. He speculates that the people behind the company may be misleading Sulek, and says the company borrowed the look of a legitimate lab supplier.
Doucette then turns to legality. He reads the site's terms, which describe the products as for laboratory research only and not for human use, and says anyone buying outside that description is breaking the law. He links recent voluntary shutdowns of other peptide sellers to enforcement pressure, and says a parent who finds a minor's order could sue the seller.
Throughout, Doucette discloses that he owns AlgoRX, which he describes as doctor-prescribed peptides from compounding pharmacies, and he promotes a discount code for it. He also says he once sold steroids and turned down large offers to promote peptides. Treat the video as one commentator's opinion with a commercial stake, not a verified investigation. It covers cagrilintide only briefly, and it says little about how any peptide works.
On each compound
Cagrilintide4:38
Doucette describes cagrilintide as the next wave after Ozempic, tirzepatide and retatrutide. He says the site's lab report shows no molecular weight check, and he claims the seller cannot actually be making it.
See how your DNA reads CagrilintideWhat this video doesn’t settle
- Doucette offers no independent test of the site's products, so his claim that they are probably fake rests on his reading of one lab report and a price comparison.
- He owns AlgoRX and promotes a discount code for it, so his comparison between his business and Sulek's is not a neutral assessment.
- The video does not establish who is behind the company, what Sulek actually knows about it, or whether any enforcement action is planned.
Questions this video answers
Why does Greg Doucette say Sam Sulek's peptides may not be real?
Doucette says peptides are hard to make without a compounding pharmacy and tend to degrade. He argues the lab report relies on HPLC retention time instead of a molecular weight test, and that the low price is implausible.
Does Doucette say buying research peptides is illegal?
He says the site's terms limit use to licensed professionals doing laboratory research, so anyone else buying is, in his view, breaking the law. He calls the gray-area idea a misconception, though he says enforcement is uncertain.
What does Doucette say about the cagrilintide lab test?
He says the report lists a retention time but not the molecular weight he gives as 4409.01 g per mole. He argues that HPLC alone is not enough to prove a peptide's identity.
What is the difference between research peptides and prescribed peptides according to Doucette?
He says prescribed products from his company AlgoRX are made in compounding pharmacies and given by doctors after blood work. He says research-labelled products are not legal for human use.
Video by Greg Doucette on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
